What is ZoomRx?
Headquartered in Cambridge, Massachusetts, with a strategic presence in Chennai, India, ZoomRx operates as a specialized market research consultancy. The firm distinguishes itself through a proprietary mobile technology platform designed specifically for the healthcare sector. By integrating primary and syndicated research methodologies, ZoomRx provides pharmaceutical and biotech clients with actionable data that drives return on investment. Their approach combines traditional consultancy rigor with innovative digital tools, enabling the collection of both quantitative and qualitative insights that are essential for modern drug development and commercialization strategies.
How much funding has ZoomRx raised?
ZoomRx has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in ZoomRx
PPP
Public-Private Partnership
What's next for ZoomRx?
Following this latest infusion of capital, ZoomRx is well-positioned to scale its technological infrastructure and expand its footprint in the global healthcare analytics market. The company is expected to leverage these resources to enhance its mobile research platform, potentially incorporating advanced data analytics or artificial intelligence to further refine its tracking studies. As the pharmaceutical industry increasingly relies on real-time, high-fidelity data to inform clinical and commercial decisions, ZoomRx's focus on innovative research methodologies will likely remain a key driver of its long-term growth trajectory and competitive advantage in the life sciences consultancy space.
See full ZoomRx company page
